Page 3 - Nasdaq Siox News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Sio Gene Therapies (NASDAQ:SIOX – Get Rating) and Organigram (NASDAQ:OGI – Get Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, valuation, earnings, profitability, institutional ownership, risk and dividends. Insider and Institutional Ownership 11.0% of Organigram shares are […]

NEW YORK, Dec. 14, 2022 (GLOBE NEWSWIRE) -- Sio Gene Therapies Inc. (Nasdaq:SIOX) today announced that its Board of Directors has determined, after...

Shares of Sio Gene Therapies Inc. (NASDAQ:SIOX – Get Rating) have been assigned a consensus recommendation of “Hold” from the seven research firms that are currently covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and three have issued a buy […]

Sio Gene Therapies Inc. (NASDAQ:SIOX – Get Rating) was the target of a large drop in short interest in the month of May. As of May 15th, there was short interest totalling 204,700 shares, a drop of 37.2% from the April 30th total of 326,100 shares. Approximately 0.4% of the shares of the stock are […]

-Company Announces Termination of Licensing Agreement for GM1 and GM2 Gene Therapies with the University of Massachusetts-Company has engaged SVB...